Schonfeld Strategic Advisors LLC Terns Pharmaceuticals, Inc. Call Options Transaction History
Schonfeld Strategic Advisors LLC
- $15.4 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TERN
# of Institutions
160Shares Held
83.9MCall Options Held
473KPut Options Held
119K-
Soleus Capital Management, L.P. Greenwich, CT8.14MShares$30 Million3.16% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$27.9 Million1.14% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$25.4 Million7.51% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$20.6 Million1.37% of portfolio
-
Black Rock Inc. New York, NY4.12MShares$15.2 Million0.0% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $139M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...